000267256 001__ 267256
000267256 005__ 20190812204804.0
000267256 022__ $$a1525-0016
000267256 022__ $$a1525-0024
000267256 02470 $$a000464381003092$$2isi
000267256 037__ $$aCONF
000267256 245__ $$aEngineered Anti-CRISPR Proteins for Precision Control of CRISPR-Cas9
000267256 260__ $$c2019$$aCambridge$$bCELL PRESS
000267256 269__ $$a2019-04-22
000267256 336__ $$aConference Papers
000267256 650__ $$aBiotechnology & Applied Microbiology
000267256 650__ $$aGenetics & Heredity
000267256 650__ $$aMedicine, Research & Experimental
000267256 650__ $$aBiotechnology & Applied Microbiology
000267256 650__ $$aGenetics & Heredity
000267256 650__ $$aResearch & Experimental Medicine
000267256 700__ $$aBubeck, Felix
000267256 700__ $$aHoffmann, Mareike D.
000267256 700__ $$aHarteveld, Zander$$0251359$$g254520
000267256 700__ $$aAschenbrenner, Sabine
000267256 700__ $$aBietz, Andreas
000267256 700__ $$aNotbohm, Judith
000267256 700__ $$aStengl, Christina
000267256 700__ $$aMathony, Jan
000267256 700__ $$aWaldhauer, Max C.
000267256 700__ $$aDietz, Laura
000267256 700__ $$aBoerner, Kathleen
000267256 700__ $$aFakhiri, Julia
000267256 700__ $$aSchmelas, Carolin
000267256 700__ $$aGrimm, Dirk
000267256 700__ $$aCorreia, Bruno E.$$0249970$$g253103
000267256 700__ $$aEils, Roland
000267256 700__ $$aNiopek, Dominik
000267256 7112_ $$a22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)$$dApr 29-May 02, 2019$$cWashington, DC
000267256 773__ $$k4$$j27$$q297-297$$tMolecular Therapy
000267256 8560_ $$fbruno.correia@epfl.ch
000267256 909C0 $$mbruno.correia@epfl.ch$$zMarselli, Béatrice$$0252545$$yApproved$$pLPDI$$xU13000
000267256 909CO $$pconf$$pSTI$$ooai:infoscience.epfl.ch:267256
000267256 961__ $$apierre.devaud@epfl.ch
000267256 973__ $$aEPFL$$sPUBLISHED$$rREVIEWED
000267256 980__ $$aCONF
000267256 980__ $$aWoS
000267256 981__ $$aoverwrite